DAMON RUNYON CLINICAL INVESTIGATOR AWARD FUNDING RESEARCH FOR EARLY CAREER MD’S AND MD/PHDS. RESEARCH PROJECT FUNDED IS THE INVESTIGATION OF A BIOMARKR PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS.

PI:  Priscilla K. Brastianos, MD
Clinical Investigator
Massachusetts General Hospital
Damon Runyon Cancer Research Foundation

Close Menu